 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/12/2018 |
$0.41 |
$0.41 |
$0.33 |
$0.35 |
4.80M | | 11/13/2018 |
$0.34 |
$0.36 |
$0.34 |
$0.35 |
824.20K | | 11/14/2018 |
$0.38 |
$0.39 |
$0.31 |
$0.33 |
2.94M | | 11/15/2018 |
$0.32 |
$0.34 |
$0.31 |
$0.33 |
948.00K | | 11/16/2018 |
$0.33 |
$0.33 |
$0.32 |
$0.33 |
461.20K |
|
|
| RXi Pharmaceuticals is a clinical-stage company developing therapeutics based on its self-delivering RNAi (sd-rxRNA®) platform and Samcyprone™, a topical immunomodulator. Co.'s clinical development programs include RXI-109, an sd-rxRNA for the treatment of dermal and ocular scarring, and Samcyprone™, for the treatment of warts. Co.'s development programs also include cell-based cancer immunotherapy. Co.'s RNAi therapies are designed to silence, or down-regulate, the expression of a specific gene that may be over-expressed in a disease condition and its topical immunotherapy agent, Samcyprone™, treats diseases by inducing, enhancing or suppressing an immune response in the skin. | |
|
RXII (RXII) has the following price history information. Looking back at RXII historical stock prices for the last five trading days, on November 12, 2018, RXII opened at $0.41, traded as high as $0.41 and as low as $0.33, and closed at $0.35. Trading volume was a total of 4.80M shares. On November 13, 2018, RXII opened at $0.34, traded as high as $0.36 and as low as $0.34, and closed at $0.35. Trading volume was a total of 824.20K shares. On November 14, 2018, RXII opened at $0.38, traded as high as $0.39 and as low as $0.31, and closed at $0.33. Trading volume was a total of 2.94M shares. On November 15, 2018, RXII opened at $0.32, traded as high as $0.34 and as low as $0.31, and closed at $0.33. Trading volume was a total of 948.00K shares. On November 16, 2018, RXII opened at $0.33, traded as high as $0.33 and as low as $0.32, and closed at $0.33. Trading volume was a total of 461.20K shares.
RXII Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into RXII shares, starting with a $10,000 purchase of RXII, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/15/2014 |
|
| End date: |
11/16/2018 |
|
| Start price/share: |
$194.00 |
|
| End price/share: |
$0.33 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.83% |
|
| Average Annual Total Return: |
-80.31% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$17.03 |
|
| Years: |
3.92 |
|
|
|
| Date |
Close |
| 11/12/2018 | $0.35 | | 11/13/2018 | $0.35 | | 11/14/2018 | $0.33 | | 11/15/2018 | $0.33 | | 11/16/2018 | $0.33 |
|
|
Free RXII Email Alerts:
